LP-9(Lanthio Pharma BV)

N/A

Report date: 2024/12/10 15:07:42
NME

Base Information

Drug NameLP-9(Lanthio Pharma BV)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending
Highest Status in ChinaN/A
Originator CompaniesLanthio Pharma Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLanthio Pharma Bv
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A